Cooperative Agreement ASTWH170057

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,717,104 to adapt, produce, and pilot test a youth overdose prevention "toolkit" for use in pediatric healthcare settings. The toolkit will be developed through a community-engaged approach in Boston, MA and Vancouver, BC, two locations heavily impacted by the overdose crisis. It will provide clinicians with practical guidance on...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is providing $994,004 to Boston Medical Center Corporation (BMC) from September 30, 2024 to August 31, 2026. The goal of this study is to engage adolescents, young adults, parents, providers, pharmacists, and people who use drugs to generate insights that will guide the development of interventions to reduce overdose risk among youth. The project...

This federal Project Grant award from the National Center for Injury Prevention and Control, under the Drug-Free Communities (DFC) Support Program (CFDA 93.276), provides $125,000 annually over a 5-year period to Healing In The Hood Inc., a minority-owned non-profit organization in Blytheville, Arkansas. The funding enables the organization to lead the Opioid Prescription Drug and Synthetics (O.P.P.S.) Coalition, which aims to reduce youth (ages 12-18) use of marijuana and misuse of...

This federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $945,397 provides funding to the Magee-Womens Research Institute and Foundation, with a sub-award to the University of Pittsburgh, to adapt and evaluate a collaborative care model (CCM) for treating pregnant persons with opioid use disorder (OUD) in low-resource obstetric settings. The key objectives are to: 1) adapt the CCM for rural and low-resource...

The Department of Justice (DOJ) Office of Juvenile Justice and Delinquency Prevention (OJJDP) awarded a $748,818 Project Grant to Beginning New Outreach, Inc., a minority-owned nonprofit organization, to deliver an evidence-based substance abuse prevention program curriculum paired with positive youth development (PYD) services. The project will focus on youth ages 10-17 in Muscogee County, Georgia, providing the Narconon: Truth About Drugs prevention curriculum and PYD services in areas such as...

The Santa Clarita Valley Boys & Girls Club was awarded a $1,680,000 Project Grant from the U.S. Department of Justice's Office of Juvenile Justice and Delinquency Prevention (CFDA 16.753 Congressionally Recommended Awards) to launch the Opioid & Substance Use Prevention Initiative. This three-year initiative aims to combat the opioid epidemic in the Santa Clarita Valley and Antelope Valley communities by implementing evidence-informed strategies to prevent youth risk-taking behaviors and...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $326,410 to Berkshire Biomedical Corporation to conduct a two-phased clinical study on the use of a hand-held, automated, personalized oral liquid dispensing system called COPATM for take-home methadone medication management for patients with opioid use disorder (OUD). The Phase I feasibility study will evaluate the functionality and acceptance...

The U.S. Department of Justice's Office of Juvenile Justice and Delinquency Prevention (OJJDP) awarded a $741,975 Project Grant to Chicanos POR La Causa, Inc. (CPLC) under the Opioid Affected Youth Initiative (CFDA 16.842). The grant will fund CPLC's administration of two evidence-based programs - Project Towards No Drugs Abuse and Active Parenting of Teens: Families in Action - to reach up to 250 youth and 150 families/caregivers in Maricopa County, Arizona. The programs will provide...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,467,574 to Boston Medical Center Corporation to develop and evaluate the efficacy of a universal overdose prevention intervention for youth ages 13 to 26. The intervention aims to increase awareness of risks associated with fentanyl and other emerging drugs, knowledge of strategies to reduce overdose risk, and recognition and response to...

The Office of Justice Programs Victims of Crime awarded Community Violence Solutions (CVS) a $500,000 Project Grant under the Preventing Trafficking of Girls program (CFDA 16.035) to expand and strengthen early intervention services for girls at risk of or victims of sex trafficking from October 1, 2022 to September 30, 2025. CVS will directly provide identification, assessment, case management, crisis intervention, therapy, prevention workshops, and mentoring/leadership programming to girls...